ASA Universal Inc. d/b/a Sonage

Warning LetterOpen

United StatesIssued Nov 27, 2018

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateNov 27, 2018

Product TypeDrugs

StatusOpen

Letter Details

Firm: ASA Universal Inc. d/b/a Sonage
Location: United States
FEI Number: N/A
Country: United States
Issue Date: November 27, 2018
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata only, ASA Universal Inc., operating as Sonage, received an FDA Warning Letter on November 27, 2018, regarding drug products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. Additional details from the complete Warning Letter would be needed to identify the particular compliance issues cited.

ASA Universal Inc. d/b/a Sonage FDA Warning Letter, November 27, 2018